Today, BC Platforms (BCP), a global leader in real-world data (RWD), healthcare data management, and analytics, announces the appointment of Mukhtar Ahmed as its new Chief Executive Officer, effective February 17th, 2025. Over his 30-year career, Mukhtar has served on the boards of the National Health Service (NHS) and several venture capital and private equity-funded companies. He was […]

São Paulo – MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and technologies that drive innovation in life science, established a partnership with Oncoclínicas&Co, through OC Medicina de Precisão, which comprises Genomics, Pathology and Big Data laboratories, to expand access to cutting-edge genomic tests and strengthen diagnostic capabilities in the field of […]

Transaction To Complement Bio-Rad’s Existing Digital PCR Portfolio and Accelerate Development of Next-Generation Digital PCR Solutions HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company has entered into a binding offer to purchase all equity interests in Stilla […]

The collaboration will empower infectious disease testing for animals with a comprehensive, sequencing-based diagnostic solution for livestock and pets. Collaboration will deliver local sequencing across Europe, providing veterinarians with fast, efficient diagnostic workflows​ and support from renowned laboratories. Combining rapid data delivery and scalable technology, this partnership empowers veterinarians with deeper insights for informed treatment decisions. […]

Data on CYP27A1 Variants Available to Genetic Testing Labs Around the World Ann Arbor, MI – Genomenon, Inc., a leading provider of genomic intelligence solutions, has announced a strategic partnership with Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) to improve the awareness and diagnosis of Cerebrotendinous Xanthomatosis (CTX).The collaboration will focus on CYP27A1 gene variants, making critical genetic […]

Building on years of innovation—from the Dante Labs Genome to the Avanti Platform—Dante Omics AI introduces fully integrated solutions designed for diagnostics, biopharma and longevity. NEW YORK — Dante Genomics, a global leader in AI-driven genomic analysis, has expanded into Dante Omics AI to reflect its evolution into a multiomics platform. By integrating genomics, RNA, proteomics, and […]

SAN FRANCISCO — Sequins, a newly-funded start-up in the next generation sequencing (NGS) ecosystem, announced today the availability of their first commercial products – the Sequins Metagenomics Core Control and Whole Genome Sequencing Core Control Sets, along with an evaluation program for circulating tumor DNA Controls. These easy-to-use internal spike-in controls set a new standard for […]

EpiPlex is first platform to offer multi-target, quantitative analysis of RNA modifications to provide comprehensive detection and characterization of the epitranscriptome AlidaBio to showcase platform at Precision Medicine World Conference 2025 SAN DIEGO — Alida Biosciences (AlidaBio), an innovator in epigenomic research tools, today announced the full commercial launch of its EpiPlex™ platform, the first […]

Acquisition is the fourth for VION as it continues to expand its portfolio of proprietary products for life science research NASHVILLE, Tenn. — VION Biosciences, a life science platform company focused on specialty materials in the life science research, diagnostics, and drug discovery spaces, announced its January 2025 acquisition of San Francisco area-based BioAssay Systems, […]

Cairo, Egypt – Africa’s EVA Pharma, France’s DNA Script, and Belgium’s Quantoom Biosciences have signed a Memorandum of Understanding today, on the sidelines of the 2nd Vaccine and Other Health Products Manufacturing Forum for African Union Member States, organized by Africa CDC and hosted by the Egyptian United Procurement Authority (UPA) in Cairo. This collaboration aims to develop the first ever […]